Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

An Examination of Device Types and Features Used by Adult Electronic Nicotine Delivery System (ENDS) Users in the PATH Study, 2015-2016.

Coleman B, Chang JT, Rostron BL, Johnson SE, Das B, Del Valle-Pinero AY.

Int J Environ Res Public Health. 2019 Jul 2;16(13). pii: E2329. doi: 10.3390/ijerph16132329.

2.

Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Chang CM, Rostron BL, Chang JT, Corey CG, Kimmel HL, Sosnoff CS, Goniewicz ML, Edwards KC, Hatsukami DK, Wang Y, Del Valle-Pinero AY, Yang M, Travers MJ, Arnstein S, Taylor K, Conway K, Ambrose BK, Borek N, Hyland A, Wang L, Blount BC, van Bemmel DM.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):943-953. doi: 10.1158/1055-9965.EPI-18-0539. Epub 2019 Feb 7.

PMID:
30733305
3.

Urinary concentrations of monohydroxylated polycyclic aromatic hydrocarbons in adults from the U.S. Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Wang Y, Wong LY, Meng L, Pittman EN, Trinidad DA, Hubbard KL, Etheredge A, Del Valle-Pinero AY, Zamoiski R, van Bemmel DM, Borek N, Patel V, Kimmel HL, Conway KP, Lawrence C, Edwards KC, Hyland A, Goniewicz ML, Hatsukami D, Hecht SS, Calafat AM.

Environ Int. 2019 Feb;123:201-208. doi: 10.1016/j.envint.2018.11.068. Epub 2018 Dec 6.

4.

Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop.

Chang CM, Cheng YC, Cho TM, Mishina EV, Del Valle-Pinero AY, van Bemmel DM, Hatsukami DK.

Nicotine Tob Res. 2019 Jan 1;21(1):3-13. doi: 10.1093/ntr/ntx273.

PMID:
29253243
5.

Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop.

Chang CM, Edwards SH, Arab A, Del Valle-Pinero AY, Yang L, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):291-302. doi: 10.1158/1055-9965.EPI-16-0675. Epub 2016 Nov 9.

6.

Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.

Del Valle-Pinero AY, Sherwin LB, Anderson EM, Caudle RM, Henderson WA.

World J Gastroenterol. 2015 Jan 7;21(1):155-63. doi: 10.3748/wjg.v21.i1.155.

7.

Inverse relationship of interleukin-6 and mast cells in children with inflammatory and non-inflammatory abdominal pain phenotypes.

Henderson WA, Shankar R, Taylor TJ, Del Valle-Pinero AY, Kleiner DE, Kim KH, Youssef NN.

World J Gastrointest Pathophysiol. 2012 Dec 15;3(6):102-8. doi: 10.4291/wjgp.v3.i6.102.

8.

Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.

Del Valle-Pinero AY, Van Deventer HE, Fourie NH, Martino AC, Patel NS, Remaley AT, Henderson WA.

Clin Chim Acta. 2013 Mar 15;418:97-101. doi: 10.1016/j.cca.2012.12.032. Epub 2013 Jan 14.

9.

Morphine and MK-801 administration leads to alternative N-methyl-D-aspartate receptor 1 splicing and associated changes in reward seeking behavior and nociception on an operant orofacial assay.

Anderson EM, Del Valle-Pinero AY, Suckow SK, Nolan TA, Neubert JK, Caudle RM.

Neuroscience. 2012 Jul 12;214:14-27. doi: 10.1016/j.neuroscience.2012.04.032. Epub 2012 Apr 21.

10.

Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study.

Del Valle-Pinero AY, Martino AC, Taylor TJ, Majors BL, Patel NS, Heitkemper MM, Henderson WA.

Neurogastroenterol Motil. 2011 Dec;23(12):1092-7. doi: 10.1111/j.1365-2982.2011.01792.x. Epub 2011 Sep 23.

11.

Expression of the N-methyl-D-aspartate receptor NR1 splice variants and NR2 subunit subtypes in the rat colon.

Del Valle-Pinero AY, Suckow SK, Zhou Q, Perez FM, Verne GN, Caudle RM.

Neuroscience. 2007 Jun 15;147(1):164-73. Epub 2007 May 23.

12.

Selective up-regulation of NMDA-NR1 receptor expression in myenteric plexus after TNBS induced colitis in rats.

Zhou Q, Caudle RM, Price DD, Del Valle-Pinero AY, Verne GN.

Mol Pain. 2006 Jan 17;2:3.

13.

Spinal cord NR1 serine phosphorylation and NR2B subunit suppression following peripheral inflammation.

Caudle RM, Perez FM, Del Valle-Pinero AY, Iadarola MJ.

Mol Pain. 2005 Sep 2;1:25.

Supplemental Content

Loading ...
Support Center